Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Switching to duloxetine to ameliorate SSRI-induced sexual dysfunction

Trial Profile

Switching to duloxetine to ameliorate SSRI-induced sexual dysfunction

Phase of Trial: Phase IV

Latest Information Update: 20 Nov 2017

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Depressive disorders; Dysthymic disorder
  • Focus Adverse reactions
  • Sponsors Eli Lilly
  • Most Recent Events

    • 05 Jun 2012 Actual patient number added 3 according to ClinicalTrials.gov.
    • 15 Oct 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 25 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top